Name Change

The Company officially changed its name to Nordion Inc. on November 1, 2010. Prior to November the Company's name was MDS Inc.

Board of Directors

William Anderson_

William D. Anderson
Chairman, Board of Directors

William Anderson of Toronto, Canada, has served on the Board since February 2007, and became Chairman in February 2010. Mr. Anderson is a Chartered Accountant and a Corporate Director, having retired in 2005 after serving 14 years with BCE Inc. From 2001 to 2004, Mr. Anderson was President of BCE Ventures, and from 1997 to 2000, was Chief Financial Officer of BCE Inc. Mr. Anderson is also a director of TransAlta Corporation, Gildan Activewear Inc. and SunLife Financial Inc.

Jeffrey J. Brown

Jeffrey J. Brown
Member of the EHS & Governance Committee
Member of the Finance & Audit Committee

Jeff Brown of Corona del Mar, California was appointed to the Board in 2012. Since 2007, Mr. Brown has been the CEO and founding member of Brown Equity Partners, LLC. Previously he served as a founding partner for Forrest Binkley & Brown, a U.S. private equity/venture capital firm. Mr. Brown has served on the Board of Directors of numerous companies during his 25 years in the investment industry. He has also been Chairman of the Board of several companies in both the public and private sectors.

William Dempsey

William G. Dempsey
Chair, Human Resources & Compensation Committee

Bill Dempsey of Green Oaks, U.S., was appointed to the Board in 2008.  Mr. Dempsey was an Executive with Abbott Laboratories for 25 years, prior to his retirement in 2007.  His assignments included Executive Vice-President of the Pharmaceutical Products Group and Senior Vice-President of International Operations. Mr. Dempsey is a former Director of TAP Pharmaceutical Products Inc., and is currently a Director of TyRx, Inc., Landauer, Inc., Hospira, Inc. and the MPN Foundation.

Sean Murphy

Sean Murphy
Member of the EHS & Governance Committee
Member of the Finance & Audit Committee

Sean Murphy of Lake Forest, Illinois was appointed to the Board in 2011. He joined Evercore Partners Inc. in September 2011 as a Senior Advisor, Investment Banking. He previously served as Vice-President of Licensing and Business Development for Abbott Laboratories for 10 years, prior to his retirement in 2010. During Mr. Murphy’s 30 years of service at Abbott, he also served as President of Perclose Inc., a company in the international vascular business, which was acquired by Abbott.

Kenneth Newport

Kenneth Newport
Member of the Finance & Audit Committee

Ken Newport of Ottawa, Canada was appointed to the Board in 2010. A chartered accountant, entrepreneur and life sciences business executive, Mr. Newport served as Senior Vice-President and Executive Committee member at PRA International Inc. for three years until his retirement in 2005. In the mid-nineties he was co-founder and President of CroMedica Inc., a clinical trials contract research organization which was sold to PRA International in 2002. Mr. Newport was also a founding member of Global Biomedical Capital Corporation, Zelos Therapeutics Inc., Prime Trials Inc. and other life science organizations. He is a member of the Institute of Corporate Directors and serves on the corporate Boards of Jennerex Inc. and Medgenesis Therapeutics Inc.

Dr. Oye Olukotun

Dr. Oye Olukotun
Member of the EHS & Governance Committee

Oye Olukotun of Princeton, U.S., has served on the Board of the Company since 2010. Dr. Olukotun is the Chief Executive Officer of CardioVax Inc. He is a co-founder of VIA Pharmaceuticals and served as the Chief Medical Officer since the company's formation. He is a Board Certified Cardiologist and has more than 25 years of experience in clinical research and drug development in the pharmaceutical industry with companies such as Esperion Therapeutics, Mallinckrodt, Inc. and Bristol-Myers Squibb Company. Dr. Olukotun is also a Director of diaDexus Inc.

Janet Woodruff

Janet Woodruff
Chair, Finance & Audit Committee
Member of the Human Resources & Compensation Committee

Janet Woodruff of Vancouver, Canada, was appointed to the Board in 2011. Ms. Woodruff was Vice-President and Special Advisor of BC Hydro (2010-2011) and served BC Transmission as Interim President and Vice-President Corporate Services and CFO the previous three years. She was CFO and VP Systems Development and Performance of Vancouver Coastal Health from 2003-2007. Ms. Woodruff is a Chartered Accountant and an Institute of Corporate Directors credited director. She is a director of Capstone Infrastructure, ForisBC and the Mutual Fund Dealers Association of Canada and a former director of Pacific Northern Gas.

Steven M. West

Steve M. West
Chief Executive Officer

Steve West was appointed Chief Executive Officer of Nordion Inc. (formerly MDS Inc.) in January 2010. Mr. West, who in September 2009 was appointed Chief Operating Officer, has served as President of Nordion since April 2003. He joined MDS Capital Corp. (now Lumira Capital) in 2001 as a senior partner after serving as President, DiverseyLever Canada. His background includes various CEO assignments in Asia and the Pacific Rim, as well as international business-development responsibilities in the specialty chemicals field. Mr. West is a director and chair of the Ottawa Hospital Foundation and ISTPCanada and former chair of Lumira Capital.

footer